Recently, Chalishazar et al. observed that MYC-driven small-cell lung cancer (SCLC) preferentially depends on arginine-regulated pathways, including polyamine biosynthesis and mTOR pathway activation [44]. Here, MYC is linked to small cell lung carcinoma.